Skip to main content
. 2022 Aug 19;9:943281. doi: 10.3389/fcvm.2022.943281

Table 4.

Relationship between metabolic syndrome and carotid atherosclerosisin multivariate analysis.

Risk factors ln (TPA) Carotid plaque
β (95%CI) P References OR (95%CI) P
MetS 0.18 (0.08, 0.27) <0.001 No 1.20 (1.01, 1.42) 0.036
Num. of components of MetS <3
   3–4 0.16 (0.07, 0.26) 0.001 1.21 (1.02, 1.44) 0.030
   5 0.28 (0.12, 0.44) 0.001 1.47 (1.09, 1.98) 0.011
MetS components
   Raised BP 0.19 (0.07, 0.31) 0.002 No 1.49 (1.21, 1.83) <0.001
   Raised FPG 0.06 (−0.03, 0.14) 0.173 No 1.05 (0.90, 1.22) 0.559
   Reduced HDL–C 0.05 (−0.04, 0.15) 0.276 No 1.06 (0.89, 1.26) 0.530
   Raised TG 0.06 (−0.03, 0.15) 0.184 No 1.14 (0.96, 1.34) 0.128
   Abdominal obesity 0.06 (−0.01, 0.23) 0.054 No 0.86 (0.69, 1.06) 0.152

MetS, Metabolic syndrome; FBG, fasting blood glucose; BP, blood pressure; TG, triglycerides; HDL–C, high density lipoprotein cholesterol.

Multivariate analysis in MetS, Num. of MetS components and MetS components were adjusted by age, education, smoking status, LDL–C.